93 related articles for article (PubMed ID: 14985095)
1. Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo.
Van Themsche C; Potworowski EF; St-Pierre Y
Biochem Biophys Res Commun; 2004 Mar; 315(4):884-91. PubMed ID: 14985095
[TBL] [Abstract][Full Text] [Related]
2. A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression.
Demers M; Magnaldo T; St-Pierre Y
Cancer Res; 2005 Jun; 65(12):5205-10. PubMed ID: 15958565
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.
Choi J; Choi K; Benveniste EN; Rho SB; Hong YS; Lee JH; Kim J; Park K
Cancer Res; 2005 Jul; 65(13):5554-60. PubMed ID: 15994927
[TBL] [Abstract][Full Text] [Related]
4. Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma.
Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
Arch Dermatol Res; 2005 Oct; 297(4):154-60. PubMed ID: 16047212
[TBL] [Abstract][Full Text] [Related]
5. Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice.
Taniwaki K; Fukamachi H; Komori K; Ohtake Y; Nonaka T; Sakamoto T; Shiomi T; Okada Y; Itoh T; Itohara S; Seiki M; Yana I
Cancer Res; 2007 May; 67(9):4311-9. PubMed ID: 17483344
[TBL] [Abstract][Full Text] [Related]
6. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
Tang Y; Kesavan P; Nakada MT; Yan L
Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463
[TBL] [Abstract][Full Text] [Related]
7. A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.
McCawley LJ; Crawford HC; King LE; Mudgett J; Matrisian LM
Cancer Res; 2004 Oct; 64(19):6965-72. PubMed ID: 15466188
[TBL] [Abstract][Full Text] [Related]
8. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
[TBL] [Abstract][Full Text] [Related]
9. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
[TBL] [Abstract][Full Text] [Related]
10. Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors in vivo.
Van Themsche C; Alain T; Kossakowska AE; Urbanski S; Potworowski EF; St-Pierre Y
J Immunol; 2004 Sep; 173(6):3605-11. PubMed ID: 15356104
[TBL] [Abstract][Full Text] [Related]
11. Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer.
Acuff HB; Sinnamon M; Fingleton B; Boone B; Levy SE; Chen X; Pozzi A; Carbone DP; Schwartz DR; Moin K; Sloane BF; Matrisian LM
Cancer Res; 2006 Aug; 66(16):7968-75. PubMed ID: 16912171
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous metastasis in matrix metalloproteinase 3-deficient mice.
Juncker-Jensen A; Rømer J; Pennington CJ; Lund LR; Almholt K
Mol Carcinog; 2009 Jul; 48(7):618-25. PubMed ID: 19058297
[TBL] [Abstract][Full Text] [Related]
14. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
16. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas.
Nabeshima K; Suzumiya J; Nagano M; Ohshima K; Toole BP; Tamura K; Iwasaki H; Kikuchi M
J Pathol; 2004 Mar; 202(3):341-51. PubMed ID: 14991900
[TBL] [Abstract][Full Text] [Related]
17. Gelatinase B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma.
Aoudjit F; Masure S; Opdenakker G; Potworowski EF; St-Pierre Y
Int J Cancer; 1999 Aug; 82(5):743-7. PubMed ID: 10417774
[TBL] [Abstract][Full Text] [Related]
18. Ganglioside GD1a negatively regulates matrix metalloproteinase-9 expression in mouse FBJ cell lines at the transcriptional level.
Hu D; Man Z; Wang P; Tan X; Wang X; Takaku S; Hyuga S; Sato T; Yao X; Yamagata S; Yamagata T
Connect Tissue Res; 2007; 48(4):198-205. PubMed ID: 17653976
[TBL] [Abstract][Full Text] [Related]
19. Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.
Owen JL; Torroella-Kouri M; Iragavarapu-Charyulu V
Int J Mol Med; 2008 Jan; 21(1):125-34. PubMed ID: 18097625
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
Lakka SS; Gondi CS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Rao JS
Oncogene; 2004 Jun; 23(27):4681-9. PubMed ID: 15122332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
